Explore

Trendline Trendline
Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call

Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call

Vanda Pharmaceuticals to Release Q1 2026 Financial Results, Hosting Conference Call
Trendline Trendline
Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast

Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast

Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast
Trendline Trendline
Avantor Reports Q1 2026 Financial Results, Reaffirms Full-Year Guidance

Avantor Reports Q1 2026 Financial Results, Reaffirms Full-Year Guidance

Avantor Reports Q1 2026 Financial Results, Reaffirms Full-Year Guidance
Trendline Trendline
Eli Lilly Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance

Eli Lilly Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance

Eli Lilly Reports Strong Q1 2026 Financial Results and Raises Full-Year Guidance
Trendline Trendline
Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026

Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026

Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026
Trendline Trendline
Azenta Schedules Fiscal 2026 Q2 Earnings Call and Webcast for May 6

Azenta Schedules Fiscal 2026 Q2 Earnings Call and Webcast for May 6

Azenta Schedules Fiscal 2026 Q2 Earnings Call and Webcast for May 6
Trendline Trendline
Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights

Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights

Nektar Therapeutics to Announce First Quarter Financial Results, Impacting Stakeholder Insights
Trendline Trendline
CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance

CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance

CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance
Trendline Trendline
ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call

ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call

ADC Therapeutics to Announce Q1 2026 Financial Results in Upcoming Conference Call
Trendline Trendline
Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community

Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community

Travere Therapeutics to Announce Q1 2026 Financial Results, Impacting Rare Disease Community
Trendline Trendline
Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings

Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings

Zimmer Biomet Reports Strong Q1 2026 Financial Results with Increased Earnings
Trendline Trendline
Travere Therapeutics to Announce Q1 2026 Financial Results, Hosts Conference Call

Travere Therapeutics to Announce Q1 2026 Financial Results, Hosts Conference Call

Travere Therapeutics to Announce Q1 2026 Financial Results, Hosts Conference Call